Accelerated Approval: US FDA Panel To Reconsider Six Indications For Checkpoint Inhibitors

 
• By Sue Sutter
  
Time To Rethink
FDA is rethinking the accelerated approval of a host of indications for immunotherapies. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers